Dialogues

Aug 11, 2025, 06:41

Why Are Pediatric Cancer Trials Still Underfunded? Insights from ESMO and Middle East Leaders

Welcome to the Second Global Oncothon, held in collaboration with the International Society of Pediatric Oncology (SIOP) and OncoDaily, on the occasion of International Childhood Cancer Day.

This powerful session is moderated by Amalya Sargsyan and features two global oncology leaders: Prof. Giuseppe Curigliano – Director of Early Drug Development at the European Institute of Oncology, Milan, and President-Elect of ESMO Prof. Hesham El-Ghazaly – CEO of AlpeCure Oncology Center and Professor at Ain Shams University, Cairo.

Together, they explore some of the most pressing challenges and opportunities in pediatric oncology today.

Urgent need for investment in pediatric cancer research
Pediatric and adolescent underrepresentation in clinical trials
Disparities in access to care and funding across regions
The humanitarian role of cancer centers during conflict and war
The importance of survivorship care and long-term support
Call for global collaboration, funding, and awareness
Launch of the $10 donation challenge to fund pediatric cancer research
Prof. Curigliano and Prof. El-Ghazaly share both clinical insight and lived experience treating children from areas of conflict—underscoring the moral and medical imperative to support every child, everywhere.

Adolescent Cancer Cance Research cancer cancer survivorship Childhood Cancer clinical trials Giuseppe Curigliano Hesham El Ghazaly OncoDaily Oncology pediatric oncology SIOP

Hubert Caron Retires from Roche-Genentech

Ramy Sedhom: Palliative Care Isn’t Just about When. It’s about Who, What, and How

Miriam Mutebi: One Small Grant, One Big Difference

Jasmine Kamboj: How We Bring Ourselves to the Table as Leaders

Zongertinib Gets FDA Green Light for HER2+ NSCLC